Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from
Guillain-Barré syndrome is an immune-mediated neuropathy that was
reported following multiple vaccines. We present the case of a gentleman
who developed GBS 20 days after the second dose of COVID-19 vaccination.
It is important to mention that more research is needed to establish an
association between COVID-19 vaccine and GBS.